Teva Parenteral Medicines, Inc. Irvine, CA. Form 483 (Inspectional Observations). 7/13/09 – 7/24/09
QUALITY SYSTEM OBSERVATION 1 Procedures describing the handling ohvritten and oral complaints related to drug products are defic
Teva API India Private Ltd. - Form 483, 2019-04-16 - Redica Systems Store
Teva Parenteral Medicines, Inc. Irvine, CA. Form 483 (Inspectional Observations). 7/13/09 – 7/24/09
Teva Parenteral Medicines, Inc. Irvine, CA. Form 483 (Inspectional Observations). 7/13/09 – 7/24/09
Teva Parenteral Medicines, Inc. Irvine, CA. Form 483 (Inspectional Observations). 7/13/09 – 7/24/09
Celltrion hit with Form 483 over troublesome Incheon plant
UPDATED: Teva's struggling sterile plant hit with FDA warning letter | Fierce Pharma
FDA found big problems a year ago at Chinese plant now recalling tainted valsartan | Fierce Pharma
Teva API India Private Ltd. - Form 483, 2023-07-18 - Redica Systems Store
Teva Parenteral Medicines, Inc. Irvine, CA. Form 483 (Inspectional Observations). 7/13/09 – 7/24/09
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Teva Pharmaceuticals on LinkedIn: #huntingtonsdisease #tardivedyskinesia #fdaapproval #fdaapproved… | 27 comments
FDA cites 'significant' sterility concern at Teva injectables plant | Fierce Pharma
Teva Recalls Drug Vials, Shuts Facility Over Mold Concerns - TheStreet
Teva Puerto Rico LLC - Form 483, 2011-09-11 - Redica Systems Store
Teva Czech Industries s.r.o - Form 483, 2017-03-24 - Redica Systems Store
Assia Chemical Industries Ltd. - Teva Tech Site - Form 483, 2016-04-14 - Redica Systems Store
Teva Parenteral Medicines, Inc. - Form 483, 2008-09-04 - Redica Systems Store
/cloudfront-us-east-2.images.arcpublishing.com/reuters/CCBS56SBRRKUDM7JEVVE3UOQEE.jpg "Teva halts output at U.S. drug plant after FDA flags concerns | Reuters")
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Plant issues plague Celltrion and Teva as FDA issues two biosimilars CRLs
Teva Parenteral Medicines, Inc. - Form 483, 2003-08-29 - Redica Systems Store
Analysis of FDA Infrared 483 Citations: Have You a Data Integrity Problem?
Teva Parenteral Medicines, Inc. Irvine, CA. Form 483 (Inspectional Observations). 7/13/09 – 7/24/09
Despite Form 483 from FDA, Alvotech says it's in position to win 2 key biosimilar nods | Fierce Pharma
How to Respond FDA 483 Observations - Pharma Interview
